Cocrystal Pharma, Inc.COCPNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-9.5%
5Y CAGR-5.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-9.5%/yr
vs +7.2%/yr prior
5Y CAGR
-5.2%/yr
Recent deceleration
Acceleration
-16.7pp
Decelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.25M | -20.4% |
| 2024 | $5.34M | -10.8% |
| 2023 | $5.99M | +4.3% |
| 2022 | $5.75M | +5.9% |
| 2021 | $5.43M | -2.5% |
| 2020 | $5.57M | +14.5% |
| 2019 | $4.86M | +11.7% |
| 2018 | $4.35M | +78.4% |
| 2017 | $2.44M | -41.1% |
| 2016 | $4.14M | - |